Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Filing growth compares 2021 (68 records) with 2024 (9) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 1,186 records in scope (CR5), not by the ranked leaders only.
This dataset tracks 1,186 patent families filed against a search string combining MRI system/scanner terminology with RF coil design claims — phased-array coils, high-density coil arrays, flexible receive coils — restricted to the core measurement and diagnostic IPC classes (G01R33/34, G01R33/36, A61B5/055). Coverage runs from 2015 through the 2026-07-31 data cut-off, meaning the most recent year is necessarily undercounted: publication typically lags filing by around 18 months, so 2025 and 2026 figures will rise as later filings publish.
The composition skews heavily toward magnetic and electric measurement (G01R) and diagnostic/surgical devices (A61B), with a meaningful secondary cluster in magnets and inductive components (H01F). Filing offices are led by the United States, followed by the EPO and WIPO's PCT route, indicating that most applicants pursue protection through the major examining authorities rather than filing narrowly in single national offices.
Two views of the same 1,186-family dataset: filing activity by year, and how records distribute across the IPC subclasses that define the coil-design search.
Filings rose to a peak of 80 in 2020, then declined through the 38 filings recorded at the 2022 midpoint down to single digits approaching 2026. Even allowing for publication lag on the most recent one to two years, the shape is a decline rather than a plateau — the RF coil claim space that drove filings through the late 2010s has largely been staked out.
G01R (1,069 records) and A61B (673) account for the bulk of filings, consistent with a technology defined by measurement hardware embedded in diagnostic systems. H01F (116) reflects the magnet and inductor engineering underlying coil construction, while G01V (59), A61N (42), A61M (36), G01N (36) and H01Q (21) mark smaller adjacent zones — several of them, notably H01Q antenna design, look under-claimed relative to how directly they bear on coil performance.
Shares are the percentage of the 1,186 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about medical imaging mri rf coil technology and every answer comes back with the patent numbers behind it.
Try EurekaA magnetic resonance imaging (MRI) system and method of magnetic resonance imaging. The preferred MRI system is of lower weight and/or uses less power than conventional MRI systems, due to one or more of magnet design, transmit and receive coil design, selection of RF pulse sequence, synchronization methods, and image reconstruction methods. Preferably, the MRI system is portable.Filed by LT Imaging Inc., 2015-09-13. Its claims span magnet, coil, pulse-sequence and reconstruction design jointly — a breadth that makes it a useful reference point for anyone assessing freedom to operate in portable or lower-power MRI systems.
View full record| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6628980B2 | Apparatus, systems, and methods for in vivo magnetic resonance imaging | 403 |
| 2 | US6675033B1 | Magnetic resonance imaging guidewire probe | 351 |
| 3 | US5964705A | MR-compatible medical devices | 339 |
| 4 | US5476095A | Intracavity probe and interface device for MRI imaging and spectroscopy | 246 |
| 5 | US20030028095A1 | Magnetic resonance imaging probe | 227 |
| 6 | US5348010A | Intracavity probe and interface device for MRI imaging and spectroscopy | 181 |
| 7 | US20150119689A1 | Identifying individual target sites for transcranial magnetic stimulation applications | 177 |
| 8 | US5572132A | MRI probe for external imaging | 177 |
| 9 | US20160069968A1 | Low field magnetic resonance imaging methods and apparatus | 159 |
| 10 | US5382904A | Structured coil electromagnets for magnetic resonance imaging and method for fabricating the same | 152 |
Citation counts favour older records simply because they have had longer to be cited within the searched corpus — read them as a signal of influence on subsequent filings, not as a ranking of present-day relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three read-throughs from the trend, composition and citation data that matter more for a filing or freedom-to-operate decision than the raw counts alone.
Filings peaked at 80 in 2020 and have declined every year since, with 2022's midpoint figure of 38 already confirming the downturn rather than a one-year anomaly. New entrants filing now are working in a claim space that earlier filers have had a decade to occupy.
G01R33/34 and G01R33/36 — the core measurement subclasses — anchor the great majority of filings, with A61B diagnostic-system claims layered closely alongside. H01Q antenna-adjacent filings, at only 21 records, look thin given how much coil design borrows from antenna theory.
Several of the historically most active assignees, including major imaging OEMs, recorded zero filings in the latest year with -100% YoY change. That pattern is consistent with mature portfolios being maintained rather than expanded, not with a shrinking market.
The United States (506), EPO (255) and WIPO PCT route (140) account for the large majority of receiving-office activity, with Canada, India and Australia trailing well behind. Applicants pursuing broad protection are routing through PCT rather than filing nationally in secondary markets.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to medical imaging mri rf coil technology, with the prior art for and against each one.
Concentration sits with a handful of long-standing imaging OEMs and research institutions, several of which show no filings in the most recent year. Co-assignee pairs point to hospital-industry and intra-company IP-holding structures rather than new joint ventures.
The strongest co-assignee links — a university paired with a surgical-imaging spinout, and a major imaging OEM paired with its own IP-holding subsidiary — reflect internal corporate structuring and long-run academic-industry ties rather than fresh joint filings.
Several major imaging companies and a university research foundation show zero filings in the latest year. Given publication lag, this reads as a pause in new priority filings rather than withdrawal from the field.
Alongside the large imaging OEMs, university and research-foundation assignees appear repeatedly in the ranking, indicating that a meaningful share of foundational coil-design IP originates in academic labs before licensing or assignment to industry.
| Assignee | Recent year | YoY |
|---|---|---|
| Koninklijke Philips N.V. (Royal Philips) | 0 | -100% |
| Promaxo, Inc. | 0 | -100% |
| General Electric Company | 0 | — |
| General Hospital Corporation (Massachusetts General Hospital) | 0 | -100% |
| PICKER INT INC | 0 | — |
| The Regents of the University of California | 0 | — |
| Hyperfine Research, Inc. | 0 | — |
| Advanced Electric Co., Ltd. | 0 | — |
The trend and composition data point to a mature, concentrated field with specific thin spots. Turning that into a filing or freedom-to-operate decision means going claim-by-claim in the areas flagged above.
The most-cited records in this corpus cover foundational coil and probe designs; newer filings build on them incrementally. A claim chart against the top-cited records is the fastest way to see what is actually blocked.
Explore in Patsnap EurekaZero recent-year filings from major OEMs does not mean the portfolio is inactive. Continuations and divisionals can extend enforceable claim scope years after the original priority date.
Explore in Patsnap EurekaH01Q's thin 21-record footprint relative to G01R's 1,069 suggests real white space at the antenna-coil boundary. A first-claim draft here should specify impedance-matching structure rather than general coil geometry.
Explore in Patsnap EurekaFiling activity in this dataset concentrates among a small group of long-standing imaging OEMs and research institutions rather than a single dominant holder. Several of the most historically active assignees show zero filings in the most recent year, which points to mature, defensively maintained portfolios rather than active expansion. A ranking of specific assignees and their family counts is rendered in the players table on this page; treat recent-year figures as understated due to publication lag.
No — filings peaked at 80 in 2020 and have declined every year since, with the 2022 midpoint figure of 38 confirming a genuine downturn rather than a one-year fluctuation. By the most recent year, filings had fallen to a handful. Some of that apparent decline is an artefact of the roughly 18-month gap between filing and publication, but the multi-year trend predates any lag effect and reflects real cooling in new filing activity.
The IPC composition shows a strong skew toward core measurement claims (G01R, 1,069 records) and diagnostic-system claims (A61B, 673), with the antenna-adjacent H01Q subclass carrying only 21 records despite its technical relevance to coil impedance and array design. Flexible-coil conformal geometry and high-density channel multiplexing also show thinner representation relative to how often they come up in commercial coil designs. These are reasonable starting points for a novelty search before drafting new claims.
CA2884097A1, filed by LT Imaging Inc. in 2015, describes an MRI system aimed at lower weight and power consumption, achieved through combinations of magnet design, transmit/receive coil design, RF pulse sequencing, synchronization methods and image reconstruction. Its breadth — spanning coil design together with magnet and reconstruction elements — makes it a useful reference for anyone assessing portable or lower-power MRI systems, since a narrow coil-only design may still need to clear this combination claim. It should be checked directly rather than relied on secondhand, since claim scope in the granted family can differ from the published application.
The United States receiving office leads with 506 records in this dataset, followed by the EPO at 255 and the WIPO PCT route at 140. Canada, India and Australia trail well behind. This distribution suggests most applicants seeking meaningful protection route through the US, EPO or PCT rather than filing narrowly in secondary national offices, which matters for anyone scoping a freedom-to-operate search outside those three jurisdictions.
Go past this page: query the whole medical imaging mri rf coil technology corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.